Advertisement
Organisation › Details
Genovis (Group)
Genovis’ business concept is to apply its knowledge and imagination to design and provide innovative tools for development of the drugs of the future. Today Genovis sells several enzyme products known as SmartEnzymes™ all over the world in innovative product formats that facilitate development and quality control of biological drugs. The Group consists of Genovis AB and the wholly owned subsidiary Genovis Inc. (US). Genovis’ shares are listed on NASDAQ First North Stockholm and Erik Penser Bank is the Company’s Certified Adviser. *
Start | 2009-01-22 existent | |
Today | Genovis AB | |
Industry | industrial enzyme | |
Industry 2 | transfection reagents | |
Person | Olsson, Fredrik (Genovis 201906 CEO) | |
Person 2 | Humaloja, Johny (Genovis 201908– CFO before Biogen + Boston Scientific) | |
Region | Lund | |
Country | Sweden | |
Street | 2 Scheelevägen Medicon Village | |
City | 22007 Lund | |
Tel | +46-46-101230 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
Currency | SEK | |
Annual sales | 61,029,721 (net sales, consolidated (2020) 2020-12-31) | |
Profit | 6,445,902 (2020-12-31) | |
Cash | 44,117,801 (2020-12-31) | |
* Document for »About Section«: Genovis AB. (6/19/19). "Press Release: Genovis AB Hires CFO". | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Genovis (Group)
- [1] Genovis AB. (4/13/21). "Press Release: Genovis and Waters Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization"....
- [2] Genovis AB. (6/19/19). "Press Release: Genovis AB Hires CFO"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top